Dandan Geng Yingnan Wang Xin Zhang Chenguang Zhao Yao Fan Chang Liu Jinmei Wei Bingjie Huo Yang Zhao Fengbin Zhang Ruixing Zhang
10.3389/fonc.2022.981084
Front Oncol
2022 Aug 11;12:981084.
adrenal crisis hyperpyrexia immune checkpoint inhibitors (icis) immune-related adverse events (iraes) pembrolizumab
CC BY
https://pubmed.ncbi.nlm.nih.gov/36033475/
Case Reports
PMC9403738
36033475
Clinical course and management of insidious adrenal crisis manifested initially as hyperpyrexia secondary to pembrolizumab: Case reports and literature review
2022